Changes and Trends in the Outsourcing Landscape

Published on: 


Webinar Date/Time: Fri, May 31, 2024 11:00 AM EDT

The post-COVID world is seeing a changed outsourcing industry as contract service providers grow more flexible and smarter in a bid to meet evolving market demands. This episode of Drug Digest will explore key trends that have emerged out of the pandemic and will look ahead to where the outsourcing industry is headed in the future.

Register Free:

Event Overview:

The outsourcing landscape has seen many changes in recent years coming out of the COVID pandemic. Driven by a burgeoning pipeline of clinical-phase therapeutic candidates and the practical need for more advanced analytics, the contract services industry is hustling to meet the expected growth of new, more complex therapeutics to hit the market over the next decade. In this episode of Pharmaceutical Technology®’s Drug Digest Video series, industry experts discuss the current outsourcing landscape in the post-COVID world and the changes the pandemic has enforced in the demand for outsourced bioprocessing services.

This episode of Drug Digest is sponsored by:

  • Adare
  • Coatings Place
  • LGM Pharma
  • Marken
  • Nelson
  • Scorpius
  • Veltek

Key Learning Objectives:

  • An updated picture of the outsourcing landscape
  • A look at the largest global CDMOs today
  • Key outsourcing trends that have emerged in the past three years
  • Future outlook for global CDMOs moving forward

Who Should Attend:

  • CDMOs
  • Small-to-medium biotechs/startups
  • Drug developers
  • OEMs


Eric S. Langer
President and Managing Partner
BioPlan Associates, Inc.

Eric S. Langer has over 25 years experience in life sciences market assessment, valuation, marketing, management, and publishing. He been senior manager at biopharmaceutical supply companies and is an experienced biotechnology strategist. His team has advised hundreds of companies on marketing strategy development, valuation, pricing, and message strategy. Langer has also developed strategic plans based on quantitative analysis of market trends and buyer needs in valuation services, pricing, and analysis. He teaches graduate biotechnology marketing at Johns Hopkins University and biomedical valuation to the National Institutes of Health Graduate School.

Register Free: